Keyphrases
Prodrug
96%
Diclofenac
64%
In Vitro Release
53%
Intra-articular Administration
52%
Intra-articular Injection
43%
Naproxen
40%
Synovial Fluid
39%
In Situ Formation
34%
Interleukin-2
32%
Joint Injection
32%
Infected Patients
32%
Peripheral Blood Mononuclear Cells
32%
Sustained Action
32%
AIDS/HIV
32%
Bupivacaine
32%
Drug Release
30%
In Situ
27%
Release Medium
27%
Substituted Benzoic Acids
24%
Benzylamine
24%
Oil Solution
24%
Dialysis
23%
Ester Prodrug
21%
Microemulsion
21%
Diffusivity
21%
In Vitro Model
20%
Parenteral Depot
20%
Drug Release Rate
18%
Aqueous Solubility
18%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
18%
Drug Formulation
18%
Drug Delivery
18%
Liquid Crystalline Nanostructure
18%
Terminal Restriction Fragment
16%
Drug Candidates
16%
Ultraviolet Imaging
16%
Benzylamine Derivatives
16%
Intra-articular Drug Delivery
16%
Tertiary Amine
16%
N-alkylation
16%
Electrostatic Interaction
16%
Liquid Crystalline
16%
HIV Patients
16%
Salt Formation
16%
Concomitant Drugs
16%
Multivariate Data Analysis
16%
Data Analyze Approach
16%
Kinetic Mechanism
16%
Degradation Mechanism
16%
Anti-inflammatory Agents
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prodrug
100%
Drug Release
48%
Diclofenac
48%
Bupivacaine
48%
Naproxen
33%
Buffer
32%
Diatrizoic Acid
32%
Lidocaine
32%
Celecoxib
32%
Capillary Electrophoresis
32%
Medium Chain Triacylglycerol
31%
Benzoic Acid Derivative
24%
Benzylamine
21%
Microemulsion
21%
Pharmacokinetic
19%
Concomitant Drug
16%
Benzylamine Derivative
16%
Salt Formation
16%
Acetonitrile
16%
Methanol
16%
Psychotropic Agent
16%
Antiinflammatory Agent
16%
Morphine
16%
Agarose
16%
Aromatic Compound
16%
Liquid Crystal
16%
Tertiary Amine
16%
Peptidomimetics
16%
Immobility
16%
Cohort Study
16%
Imidazole Derivative
16%
Propylene Glycol
16%
Human Immunodeficiency Virus Infection
16%
HIV
16%
